GALECTIN THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

12 апр 2024 09:45:05 Источник NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

11 апр 2024 15:48:32 Источник NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

10 апр 2024 10:53:14 Источник NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

09 апр 2024 09:50:38 Источник NetDania Notify

Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis

09 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

08 апр 2024 16:13:55 Источник NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

05 апр 2024 09:46:14 Источник NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

04 апр 2024 12:26:47 Источник NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

03 апр 2024 12:18:08 Источник NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

02 апр 2024 12:37:00 Источник NetDania Notify

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

29 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

22 мар 2024 09:45:05 Источник NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

21 мар 2024 11:50:02 Источник NetDania Notify

Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development

12 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

13 ноя 2023 08:45:52 Источник Nasdaq GlobeNewswire

Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

13 ноя 2023 08:00:01 Источник Nasdaq GlobeNewswire

Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2023, Hosted by the AASLD

03 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

Galectin Therapeutics to Participate in the H.C. Wainwright 7th Annual NASH Investor Conference on October 24, 2023

23 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Galectin Therapeutics Announces Nomination of Dr. Benjamin S. Carson, Sr. to Board of Directors

12 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Galectin Therapeutics Reports the Positive Outcome of the Fourth Data and Safety Monitoring Board Meeting for NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Portal Hypertension Caused by Non-Alcoholic SteatoHepatitis Liver Cirrhosis

03 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire